Unexpectedly, no activity was seen in a trial of anti-PD-1 therapy for R/R chronic lymphocytic leukemia (CLL) although PD-L1-PD-1-mediated T cell dysfunction has been described (5–7). Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.